67 related articles for article (PubMed ID: 2381458)
1. Serum deoxythymidine kinase as a progressive marker of hematological malignancy.
Doi S; Naito K; Yamada K
Nagoya J Med Sci; 1990 Mar; 52(1-4):19-26. PubMed ID: 2381458
[TBL] [Abstract][Full Text] [Related]
2. [Serum deoxythymidine kinase in hematological malignancy].
Naito K; Yamada K
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3221-6. PubMed ID: 3196040
[TBL] [Abstract][Full Text] [Related]
3. An in-house assay for serum deoxythymidine kinase.
Seah LH; Ton SH; Cheong SK; Hamidah NH
Malays J Pathol; 1991 Dec; 13(2):109-13. PubMed ID: 1823092
[TBL] [Abstract][Full Text] [Related]
4. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
[TBL] [Abstract][Full Text] [Related]
5. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
Gronowitz JS; Hagberg H; Källander CF; Simonsson B
Br J Cancer; 1983 Apr; 47(4):487-95. PubMed ID: 6849793
[TBL] [Abstract][Full Text] [Related]
6. Serum thymidine kinase in hematologic malignancies.
Luoni R; Ucci G; Riccardi A; Spriano P; Danova M; Cassano E; Molinari E; Ascari E
Haematologica; 1988; 73(1):31-5. PubMed ID: 3131202
[No Abstract] [Full Text] [Related]
7. Changes of serum thymidine kinase in children with acute leukemia.
Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
[TBL] [Abstract][Full Text] [Related]
8. [Thymidine kinase: a serum marker in clinical medicine].
Llobell Segui GJ; Blasco Ferrandiz RF; Barbero Marín A; Gómez de Terreros FJ; Callol Sánchez L
An Med Interna; 1989 Jul; 6(7):381-5. PubMed ID: 2562370
[TBL] [Abstract][Full Text] [Related]
9. Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.
Masaki Y; Itoh K; Sawaki T; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Wano Y; Hirose Y; Suzuki T; Sugai S; Umehara H
Clin Chim Acta; 2006 Sep; 371(1-2):148-51. PubMed ID: 16643879
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
[TBL] [Abstract][Full Text] [Related]
11. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
12. Behavior of activities of thymidine metabolizing enzymes in human leukemia-lymphoma cells.
Shiotani T; Hashimoto Y; Tanaka T; Irino S
Cancer Res; 1989 Mar; 49(5):1090-4. PubMed ID: 2917346
[TBL] [Abstract][Full Text] [Related]
13. [Serum thymidine kinase in the monitoring of lymphoma patients].
Rauhala A; Rantalaiho V; Almqvist A; Putkonen M
Duodecim; 1995; 111(5):428-34. PubMed ID: 8674444
[No Abstract] [Full Text] [Related]
14. [Determination of thymidine kinase in the cerebrospinal fluid as a marker of leukemic meningosis].
Musto P; Cascavilla N; Ladogana S; Modoni S; Carotenuto M
Medicina (Firenze); 1989; 9(1):49-51. PubMed ID: 2739531
[TBL] [Abstract][Full Text] [Related]
15. Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance.
Wada M; Kosaka M; Saito S; Sano T; Tanaka K; Ichihara A
J Lab Clin Med; 1993 Feb; 121(2):215-23. PubMed ID: 8433038
[TBL] [Abstract][Full Text] [Related]
16. Prognostic importance of thymidine kinase in colorectal and breast cancer.
Svobodova S; Topolcan O; Holubec L; Treska V; Sutnar A; Rupert K; Kormunda S; Rousarova M; Finek J
Anticancer Res; 2007; 27(4A):1907-9. PubMed ID: 17649793
[TBL] [Abstract][Full Text] [Related]
17. Correlation between tumor proliferation and serum levels of beta 2-microglobulin and thymidine kinase in malignant lymphomas.
Lehtinen T
Cancer Detect Prev; 1988; 12(1-6):125-31. PubMed ID: 3052829
[TBL] [Abstract][Full Text] [Related]
18. Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma.
Taylor SS; Dodkin S; Papasouliotis K; Evans H; Graham PA; Belshaw Z; Westberg S; von Euler HP
J Feline Med Surg; 2013 Feb; 15(2):142-7. PubMed ID: 23076596
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase in neoplastic haematological diseases: confirmations, doubts and new findings.
Musto P; Longo S; Morelli A; Ficola U; Falcone A; Carotenuto M
Haematologica; 1988; 73(6):545-6. PubMed ID: 3148519
[No Abstract] [Full Text] [Related]
20. Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation.
Gatt ME; Goldschmidt N; Kalichman I; Friedman M; Arronson AC; Barak V
Anticancer Res; 2015 May; 35(5):3019-26. PubMed ID: 25964590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
